About the Study

This study is designed to evaluate the efficacy of a single dose of 100 µg of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of anxiety symptoms.

Length of Study:  Approximately 56 weeks: 30 day screening period, 12 week double-blind period, and a 40 week open-label-extension.

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 74 years old
• are experiencing anxiety symptoms
• have been diagnosed with Generalized Anxiety Disorder (GAD)
• can spend the day at our facility for a 12-hour dosing session

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. 

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.